Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

ClinicalTrials.gov ID: NCT00087607

Public ClinicalTrials.gov record NCT00087607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 12:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Open-label Study Evaluating the Viral Kinetics and Pharmacokinetics of Pegasys® Plus Copegus® and PEG-Intron® Plus Rebetol® in Interferon-naïve Patients With Chronic Hepatitis C.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the viral kinetics and pharmacokinetics of Pegasys plus ribavirin and PEG-Intron plus ribavirin in interferon-naive patients with CHC. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

Study identification

NCT ID
NCT00087607
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
385 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2004 (Type not available)
Primary completion
Mar 2006 (Actual)
Completion
Apr 2006 (Actual)
Last update posted
Jul 1, 2016

2004 – 2006

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Not listed Birmingham Alabama 35295-0005 —
Not listed Little Rock Arkansas 72205 —
Not listed Sacramento California 95817 —
Not listed San Diego California 92103 —
Not listed San Diego California 92123 —
Not listed San Francisco California 94143 —
Not listed San Mateo California 94403 —
Not listed San Rafael California 94901 —
Not listed Farmington Connecticut 06030 —
Not listed Hartford Connecticut 06015 —
Not listed Bradenton Florida 34209 —
Not listed Miami Florida 33125 —
Not listed Wellington Florida 33414 —
Not listed Kansas City Kansas 66160 —
Not listed New Orleans Louisiana 70115 —
Not listed Baltimore Maryland 21205 —
Not listed Boston Massachusetts 02215 —
Not listed Burlington Massachusetts 01805 —
Not listed Detroit Michigan 48201 —
Not listed Kansas City Missouri 64131 —
Not listed St Louis Missouri 63104 —
Not listed Omaha Nebraska 68198 —
Not listed Las Vegas Nevada 89128 —
Not listed East Orange New Jersey 07018 —
Not listed Egg Harbour Township New Jersey 08234 —
Not listed Vineland New Jersey 08360 —
Not listed New York New York 10016 —
Not listed New York New York 10021 —
Not listed Poughkeepsie New York 12601 —
Not listed The Bronx New York 10467 —
Not listed Fayetteville North Carolina 28304 —
Not listed Statesville North Carolina 28677 —
Not listed Portland Oregon 97239 —
Not listed Columbia South Carolina 29204 —
Not listed Austin Texas 78758 —
Not listed Dallas Texas 75203 —
Not listed Fairfax Virginia 22031 —
Not listed Norfolk Virginia 23502 —
Not listed Roanoke Virginia 24016 —
Not listed Tacoma Washington 98405 —
Not listed Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00087607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →